Trial Profile
A Phase II Study of Adjuvant Chemotherapy Consisting of Ro09-1978/L-OHP in Patient with Resected Stage II and III Gastric Adenocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical; Yakult Honsha
- 07 Jun 2016 New trial record